Chembio Partners, Inc. (CEMI) Announces Partnership with BioTherapeutics, Inc. to Develop Point-of-Care Diagnostic Tests for Ebola and Febrile Illness
Chembio Diagnostics, a leader in point-of-care (POC) diagnostic tests for infectious diseases, today announced that it has entered into an…